Top Reasons to Attend ISOPP 2017

Top reasons you must attend the XVI International Symposium on Oncology Pharmacy Practice (ISOPP 2017), taking place from April 26 to 29 at the Budapest Marriott Hotel in Budapest, Hungary:

Advance your Practice and Build Competence
Discover and enhance how we are Sharing the Journey with our patients and colleagues. The educational program will highlight cutting edge developments and showcase key patient and practitioner perspectives. The Symposium is a unique opportunity for us to heighten our practice and continue to elevate our collaborative role within the cancer care team.

Make Connections with Oncology Pharmacy Practitioners from Around the World
During the welcome reception, refreshment breaks, lunches, poster and exhibit viewing and social events, you will interact with oncology pharmacy practitioners from around the world who are facing similar issues, solving similar problems and celebrating similar successes - all through a different lens. Make connections that will help advance your profession in so many ways. There will be lots of opportunities to network and connect with your fellow attendees.

Be Part of the ISOPP Community Advancing Cancer Care
The role of the oncology practitioner continues to grow and evolve around the globe. Make your voice heard at the ISOPP Annual General Meeting, during sessions and in the Exhibit Hall. Get involved in the Society and learn from international and locally invited speakers.

Explore Budapest and the Surrounding Area
Budapest is a city not to be missed! Hungary's capital and largest city is the country's political, cultural and commercial centre. It beautifully occupies both sides of the Danube river. Come for the Symposium and stay an additional few days to explore what the city and country have to offer.

Happy Holidays and we look forward to seeing you in Budapest - April 26 to 29, 2017!


 


 

Attila Szucs

Symposium Chair

László Székely
Symposium Annual Program Task Force
Co-Chair

Tara Leslie
Symposium Annual Program Task Force
Co-Chair